Overall Score

Growth

Revenue growth is not provided in the fresh data, so the growth outlook remains anchored to modest profitability and efficiency rather than a clear acceleration signal.

The company still shows limited reinvestment intensity, with R&D at 0% of revenue and capex at 4.0% of revenue, suggesting a conservative growth profile.

Profitability

Margins remain solid, with gross margin at 49.6%, EBIT margin at 19.9%, and net margin at 16.6%.

Returns are positive but not high enough to indicate a strong compounding engine, with ROIC at 2.9% and ROE at 8.9%.

Financial Health

Liquidity remains very weak, with a current ratio of 0.27 and cash ratio of 0.05.

Leverage is elevated, with net debt to EBITDA at 9.0x and debt to equity at 1.86x, while working capital remains deeply negative at -$5.6B.

Valuation

Valuation looks reasonable relative to cash generation, with EV/FCF at 17.5x and price to free cash flow at 7.7x.

The stock also screens at 12.97x earnings and 1.11x book value, which is not demanding for a profitable bank.

Momentum

No recent news or price-action data is provided, so momentum cannot be confirmed as improving or deteriorating.

The framework therefore stays neutral on near-term trend strength.